Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium: A comparison between E4031 and azimilide

Akiko Shiroshita-Takeshita, Hideo Mitamura, Toshiaki Sato, Kaori Shinagawa, Yasuo Kurita, Hideaki Kanki, Seiji Takatsuki, Motoki Hara, Satoshi Ogawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study was designed to evaluate the electrophysiologic effects of E4031 (a pure IKr blocker) and azimilide (AZ: a combined 1kr + IKs blocker) at various stages of atrial electrical remodeling. Twelve dogs underwent continuous rapid atrial pacing (400/min) for 14 days. The electrophysiologic study was performed on the day before as well as after 2, 7, and 14 days of rapid atrial pacing both before and after the administration of either E4031 (n = 6) or AZ (n = 6). In response to rapid atrial pacing, the atrial effective refractory period (ERP), conduction velocity, and wavelength decreased significantly at pacing cycle lengths (PCLs) of 200 and 400 ms (P < 0.05). E4031 prolonged ERP in a reverse use-dependent manner throughout the study period. AZ also prolonged ERP during the 14 days of rapid pacing. ERP prolongation at a PCL of 200 ms was significantly greater with AZ than with E4031 (P < 0.05). The effects of blocking IKr by E4031 and IKr + IKs by AZ were well preserved at various stages of atrial electrical remodeling. However, the effect of prolonging ERP at a shorter PCL was more prominent by AZ than by E4031. Thus, IKs blockade may add a favorable anti-fibrillatory effect to IKr blockade even in the remodeled atrium.

Original languageEnglish
Pages (from-to)678-685
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume41
Issue number5
DOIs
Publication statusPublished - 2003 May 1

Fingerprint

Potassium Channel Blockers
Atrial Remodeling
Canidae
Dogs
azimilide

Keywords

  • Atrial electrical remodeling
  • Atrial fibrillation
  • Atrial refractoriness
  • Potassium channel blocker
  • Wavelength

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium : A comparison between E4031 and azimilide. / Shiroshita-Takeshita, Akiko; Mitamura, Hideo; Sato, Toshiaki; Shinagawa, Kaori; Kurita, Yasuo; Kanki, Hideaki; Takatsuki, Seiji; Hara, Motoki; Ogawa, Satoshi.

In: Journal of Cardiovascular Pharmacology, Vol. 41, No. 5, 01.05.2003, p. 678-685.

Research output: Contribution to journalArticle

Shiroshita-Takeshita, Akiko ; Mitamura, Hideo ; Sato, Toshiaki ; Shinagawa, Kaori ; Kurita, Yasuo ; Kanki, Hideaki ; Takatsuki, Seiji ; Hara, Motoki ; Ogawa, Satoshi. / Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium : A comparison between E4031 and azimilide. In: Journal of Cardiovascular Pharmacology. 2003 ; Vol. 41, No. 5. pp. 678-685.
@article{6051aae27e1f48028aee3d223e600964,
title = "Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium: A comparison between E4031 and azimilide",
abstract = "This study was designed to evaluate the electrophysiologic effects of E4031 (a pure IKr blocker) and azimilide (AZ: a combined 1kr + IKs blocker) at various stages of atrial electrical remodeling. Twelve dogs underwent continuous rapid atrial pacing (400/min) for 14 days. The electrophysiologic study was performed on the day before as well as after 2, 7, and 14 days of rapid atrial pacing both before and after the administration of either E4031 (n = 6) or AZ (n = 6). In response to rapid atrial pacing, the atrial effective refractory period (ERP), conduction velocity, and wavelength decreased significantly at pacing cycle lengths (PCLs) of 200 and 400 ms (P < 0.05). E4031 prolonged ERP in a reverse use-dependent manner throughout the study period. AZ also prolonged ERP during the 14 days of rapid pacing. ERP prolongation at a PCL of 200 ms was significantly greater with AZ than with E4031 (P < 0.05). The effects of blocking IKr by E4031 and IKr + IKs by AZ were well preserved at various stages of atrial electrical remodeling. However, the effect of prolonging ERP at a shorter PCL was more prominent by AZ than by E4031. Thus, IKs blockade may add a favorable anti-fibrillatory effect to IKr blockade even in the remodeled atrium.",
keywords = "Atrial electrical remodeling, Atrial fibrillation, Atrial refractoriness, Potassium channel blocker, Wavelength",
author = "Akiko Shiroshita-Takeshita and Hideo Mitamura and Toshiaki Sato and Kaori Shinagawa and Yasuo Kurita and Hideaki Kanki and Seiji Takatsuki and Motoki Hara and Satoshi Ogawa",
year = "2003",
month = "5",
day = "1",
doi = "10.1097/00005344-200305000-00003",
language = "English",
volume = "41",
pages = "678--685",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium

T2 - A comparison between E4031 and azimilide

AU - Shiroshita-Takeshita, Akiko

AU - Mitamura, Hideo

AU - Sato, Toshiaki

AU - Shinagawa, Kaori

AU - Kurita, Yasuo

AU - Kanki, Hideaki

AU - Takatsuki, Seiji

AU - Hara, Motoki

AU - Ogawa, Satoshi

PY - 2003/5/1

Y1 - 2003/5/1

N2 - This study was designed to evaluate the electrophysiologic effects of E4031 (a pure IKr blocker) and azimilide (AZ: a combined 1kr + IKs blocker) at various stages of atrial electrical remodeling. Twelve dogs underwent continuous rapid atrial pacing (400/min) for 14 days. The electrophysiologic study was performed on the day before as well as after 2, 7, and 14 days of rapid atrial pacing both before and after the administration of either E4031 (n = 6) or AZ (n = 6). In response to rapid atrial pacing, the atrial effective refractory period (ERP), conduction velocity, and wavelength decreased significantly at pacing cycle lengths (PCLs) of 200 and 400 ms (P < 0.05). E4031 prolonged ERP in a reverse use-dependent manner throughout the study period. AZ also prolonged ERP during the 14 days of rapid pacing. ERP prolongation at a PCL of 200 ms was significantly greater with AZ than with E4031 (P < 0.05). The effects of blocking IKr by E4031 and IKr + IKs by AZ were well preserved at various stages of atrial electrical remodeling. However, the effect of prolonging ERP at a shorter PCL was more prominent by AZ than by E4031. Thus, IKs blockade may add a favorable anti-fibrillatory effect to IKr blockade even in the remodeled atrium.

AB - This study was designed to evaluate the electrophysiologic effects of E4031 (a pure IKr blocker) and azimilide (AZ: a combined 1kr + IKs blocker) at various stages of atrial electrical remodeling. Twelve dogs underwent continuous rapid atrial pacing (400/min) for 14 days. The electrophysiologic study was performed on the day before as well as after 2, 7, and 14 days of rapid atrial pacing both before and after the administration of either E4031 (n = 6) or AZ (n = 6). In response to rapid atrial pacing, the atrial effective refractory period (ERP), conduction velocity, and wavelength decreased significantly at pacing cycle lengths (PCLs) of 200 and 400 ms (P < 0.05). E4031 prolonged ERP in a reverse use-dependent manner throughout the study period. AZ also prolonged ERP during the 14 days of rapid pacing. ERP prolongation at a PCL of 200 ms was significantly greater with AZ than with E4031 (P < 0.05). The effects of blocking IKr by E4031 and IKr + IKs by AZ were well preserved at various stages of atrial electrical remodeling. However, the effect of prolonging ERP at a shorter PCL was more prominent by AZ than by E4031. Thus, IKs blockade may add a favorable anti-fibrillatory effect to IKr blockade even in the remodeled atrium.

KW - Atrial electrical remodeling

KW - Atrial fibrillation

KW - Atrial refractoriness

KW - Potassium channel blocker

KW - Wavelength

UR - http://www.scopus.com/inward/record.url?scp=0037406319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037406319&partnerID=8YFLogxK

U2 - 10.1097/00005344-200305000-00003

DO - 10.1097/00005344-200305000-00003

M3 - Article

C2 - 12717097

AN - SCOPUS:0037406319

VL - 41

SP - 678

EP - 685

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 5

ER -